Kc Investment Advisors, LLC Abbott Laboratories Transaction History

Kc Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $32,764 - $39,601	-321 Reduced 11.06%	2,581 $280,000
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $23,602 - $28,781	207 Added 7.68%	2,902 $343,000
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $90,459 - $110,763	783 Added 40.95%	2,695 $379,000
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $8,049 - $8,905	69 Added 3.74%	1,912 $226,000
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $194,970 - $229,508	1,843 New	1,843 $214,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Kc Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Kc Investment Advisors, LLC with notifications on news.